超声衰减成像:儿童肝脂肪变无创定量评估的可重复替代方法
该研究纳入174例儿童(147例有脂肪变危险因素,27例无危险因素),采用B型超声和超声衰减成像测量衰减系数,评估其与B型超声脂肪变分级的相关性及观察者间一致性。结果显示衰减系数在两组间及不同脂肪变分级间有显著差异,观察者间一致性优秀(ICC 0.94),与B型超声评分正相关(r=0.87和0.86)。作者认为超声衰减成像对儿童脂肪变的诊断和随访有前景,尤其对B型超声可检测的低级别脂肪变提供更可重复的分类。
要点
- 超声衰减成像测量衰减系数在儿童肝脂肪变评估中观察者间一致性优秀(ICC 0.94)。
- 衰减系数中位数在有危险因素组为0.65 dB/cm/MHz,无危险因素组为0.54 dB/cm/MHz。
- 衰减系数与B型超声脂肪变评分正相关(观察者1 r=0.87,观察者2 r=0.86)。
核心结论
- 超声衰减成像对儿童脂肪变的诊断和随访有前景,尤其对B型超声可检测的低级别脂肪变提供更可重复的分类。
研究设计与样本
- 研究纳入2021年7月至11月174例患者,分为有脂肪变危险因素组(n=147)和无危险因素组(n=27),均行B型超声(两名观察者)和超声衰减成像(两次独立 session,两名不同观察者)。
诊断标准与关键数值
- 采用B型超声将脂肪变分为4级(0级无,1级轻度,2级中度,3级重度);衰减系数中位数在有危险因素组为0.65(0.59-0.69)dB/cm/MHz,无危险因素组为0.54(0.52-0.56)dB/cm/MHz;观察者间ICC为0.94(95% CI 0.92-0.96),κ=0.77(P<0.001);与B型超声评分相关系数观察者1 r=0.87(P<0.001),观察者2 r=0.86(P<0.001);B型超声评估脂肪变的观察者间κ分别为0.49和0.55(P<0.001)。
临床应用与阅片要点
- 作者认为超声衰减成像对儿童脂肪变的诊断和随访有前景,尤其对B型超声可检测的低级别脂肪变提供更可重复的分类。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Pediatric hepatic steatosis is a global public health concern, as an increasing number of children are affected by this condition. Liver biopsy is the gold standard diagnostic method; however, this procedure is invasive. Magnetic resonance imaging (MRI)-derived proton density fat fraction has been accepted as an alternative to biopsy. However, this method is limited by cost and availability. Ultrasound (US) attenuation imaging is an upcoming tool for noninvasive quantitative assessment of hepatic steatosis in children. A limited number of publications have focused on US attenuation imaging and the stages of hepatic steatosis in children.
OBJECTIVE: To analyze the usefulness of ultrasound attenuation imaging for the diagnosis and quantification of hepatic steatosis in children.
MATERIAL AND METHODS: Between July and November 2021, 174 patients were included and divided into two groups: group 1, patients with risk factors for steatosis (n = 147), and group 2, patients without risk factors for steatosis (n = 27). In all cases, age, sex, weight, body mass index (BMI), and BMI percentile were determined. B-mode US (two observers) and US attenuation imaging with attenuation coefficient acquisition (two independent sessions, two different observers) were performed in both groups. Steatosis was classified into four grades (0: absent, 1: mild, 2: moderate and 3: severe) using B-mode US. Attenuation coefficient acquisition was correlated with steatosis score according to Spearman's correlation. Attenuation coefficient acquisition measurements' interobserver agreement was assessed using intraclass correlation coefficients (ICC).
RESULTS: All attenuation coefficient acquisition measurements were satisfactory without technical failures. The median values for group 1 for the first session were 0.64 (0.57-0.69) dB/cm/MHz and 0.64 (0.60-0.70) dB/cm/MHz for the second session. The median values for group 2 for the first session were 0.54 (0.51-0.56) dB/cm/MHz and 0.54 (0.51-0.56) dB/cm/MHz for the second. The average attenuation coefficient acquisition was 0.65 (0.59-0.69) dB/cm/MHz for group 1 and 0.54 (0.52-0.56) dB/cm/MHz for group 2. There was excellent interobserver agreement at 0.94 (95% CI 0.92-0.96). There was substantial agreement between both observers (κ = 0.77, with a P < 0.001). There was a positive correlation between ultrasound attenuation imaging and B-mode scores for both observers (r = 0.87, P < 0.001 for observer 1; r = 0.86, P < 0.001 for observer 2). Attenuation coefficient acquisition median values were significantly different for each steatosis grade (P < 0.001). In the assessment of steatosis by B-mode US, the agreement between the two observers was moderate (κ = 0.49 and κ = 0.55, respectively, with a P < 0.001 in both cases).
CONCLUSION: US attenuation imaging is a promising tool for the diagnosis and follow-up of pediatric steatosis, which provides a more repeatable form of classification, especially at low levels of steatosis detectable in B-mode US.
引用
- Dardanelli, Orozco, Oliva, et al. Ultrasound attenuation imaging: a reproducible alternative for the noninvasive quantitative assessment of hepatic steatosis in children. Pediatr Radiol. 2023. PMID: 36869263. doi:10.1007/s00247-023-05601-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。